SEC Form 4 · accession 0001209191-16-126652
Pacira BioSciences, Inc. · PCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lauren Bullaro Riker
Officer — Vice President, Finance
Period of report
Jun 6, 2016
Accepted (ET)
Jun 8, 2016 · 7:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001396814
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 6, 2016 | S | 321 | $47.199 | D | 5,945 | D | |
| Common Stock | Jun 7, 2016 | S | 100 | $47.898 | D | 5,845 | D | |
| Common Stock | Jun 7, 2016 | S | 517 | $47.902 | D | 5,328 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
- F2Includes 232 shares and 54 shares of common stock acquired under the issuer's employee stock purchase plan in June 2015 and December 2015, respectively.